NCT02480751View on ClinicalTrials.gov

TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)

PHASE2CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

May 31, 2008

Conditions
Renal Insufficiency, Chronic
Interventions
DRUG

Beraprost

DRUG

Placebo

Sponsors

Collaborators (1)

Astellas Pharma Inc
All Listed Sponsors
collaborator

Astellas Pharma Inc

INDUSTRY

lead

Toray Industries, Inc

INDUSTRY

NCT02480751 - TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis) | Biotech Hunter | Biotech Hunter